ArticleClinical ophthalmology (Auckland, N.Z.)2025
Factors Affecting Ray Trace LASIK Data Acquisition in Clinical Practice: Options for Addressing Accommodation.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Visual Outcomes and Safety of Ray-Tracing-Guided Laser-Assisted In Situ Keratomileusis: A Systematic Review and Meta-Analysis.Ophthalmology and therapy · 2026Review
- Comparison of U.S. FDA Premarket Approval Studies Between Ray Tracing-Guided LASIK with InnovEyes Sightmap Versus Topography-Guided LASIK Using Custom Ablation Treatment (T-CAT).Ophthalmology and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess factors affecting successful data acquisition for InnovEyes guided ray trace LASIK. Setting: Single-site ophthalmology practice. Design: Retrospective review. Methods: A total of 1283 eyes with myopia and myopic astigmatism were assessed over 18-months for ray trace-based LASIK planning. Preoperative measurements were acquired using the InnovEyes Sightmap (Wavelight Plus, Alcon). Scan time per eye, number of scans, pupil size, calculated refraction and manifest spherical equivalent (SEQ) refraction were assessed. In a subset of eyes with significant accommodation, aberrometry-based refraction was adjusted prior to treatment, or cycloplegic measurement was used for treatment planning. In these subsets, 3-month post-operative refractive outcomes were analysed. Results: Mean noncycloplegic scanning time (11.10±14.11 minutes/eye to 8.10±3.17 minutes/eye) and number of noncycloplegic scans per eye (6.28±2.97 scans to 5.23±2.12 scans) decreased over time. In nine eyes where the wavefront SEQ (4 mm) was less myopic (by 0.5D or more) than the manifest SEQ and no adjustment was made, all achieved uncorrected distance visual acuity (UDVA) of 20/20 or better. In 274 eyes (21.4%), wavefront SEQ (4mm) was more myopic (by > 0.5D) than manifest SEQ. Surgeon adjusted treatment in 95 eyes to within 0.5D of manifest SEQ resulted in 98% achieving UDVA of 20/20 or greater. In 23 eyes treated using cycloplegic wavefront data, 96% achieved UDVA of 20/20 or greater. Conclusion: Use of the InnovEyes Sightmap system for ray trace LASIK is feasible in a clinical environment but demonstrates an operator learning curve. Accommodation during wavefront measurement can occur; this can be managed through surgeon adjustment of treatment or the use of cycloplegic wavefront data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.